BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 11272659)

  • 1. Primary angioplasty for acute myocardial infarction.
    Gordon PC
    Med Health R I; 2001 Feb; 84(2):44-50. PubMed ID: 11272659
    [No Abstract]   [Full Text] [Related]  

  • 2. Present and potential future paradigms for the treatment of ST-segment elevation acute myocardial infarction.
    Chew DP; Moliterno DJ; Herrmann HC
    J Invasive Cardiol; 2002 Feb; 14 Suppl A():3A-20A. PubMed ID: 11847402
    [No Abstract]   [Full Text] [Related]  

  • 3. Percutaneous coronary intervention versus thrombolysis: the definite management of st elevation myocardial infarction.
    Martinez-Ojeda J; Martinez-Toro J
    Bol Asoc Med P R; 2005; 97(4):308-14. PubMed ID: 16599071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibrinolysis and stenting in acute myocardial infarction: newlyweds destined for a 'ménage à trois'?
    McFadden EP
    Eur Heart J; 2001 Jul; 22(13):1067-9. PubMed ID: 11428845
    [No Abstract]   [Full Text] [Related]  

  • 5. Glycoprotein IIb/IIIa receptor antagonists: are we ignoring the evidence.
    Singh S; Gopal AK; Bahl VK
    Indian Heart J; 2005; 57(3):201-9. PubMed ID: 16196176
    [No Abstract]   [Full Text] [Related]  

  • 6. Primary percutaneous coronary intervention in acute myocardial infarction.
    Singh KP; Harrington RA
    Med Clin North Am; 2007 Jul; 91(4):639-55; x-xi. PubMed ID: 17640540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reperfusion in acute myocardial infarction: current concepts.
    Katritsis D; Karvouni E; Webb-Peploe MM
    Prog Cardiovasc Dis; 2003; 45(6):481-92. PubMed ID: 12800129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stenting and glycoprotein IIb/IIIa inhibition in patients with acute myocardial infarction undergoing percutaneous coronary intervention: findings from the global registry of acute coronary events (GRACE).
    Montalescot G; Van de Werf F; Gulba DC; Avezum A; Brieger D; Kennelly BM; Mazurek T; Spencer F; White K; Gore JM;
    Catheter Cardiovasc Interv; 2003 Nov; 60(3):360-7. PubMed ID: 14571488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Invasive therapy along with glycoprotein IIb/IIIa inhibitors and intracoronary stents improves survival in non-ST-segment elevation acute coronary syndromes: a meta-analysis and review of the literature.
    Bavry AA; Kumbhani DJ; Quiroz R; Ramchandani SR; Kenchaiah S; Antman EM
    Am J Cardiol; 2004 Apr; 93(7):830-5. PubMed ID: 15050484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The efficacy and safety of combination glycoprotein IIbIIIa inhibitors and reduced-dose thrombolytic therapy-facilitated percutaneous coronary intervention for ST-elevation myocardial infarction: a meta-analysis of randomized clinical trials.
    Sinno MC; Khanal S; Al-Mallah MH; Arida M; Weaver WD
    Am Heart J; 2007 Apr; 153(4):579-86. PubMed ID: 17383297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implications of upstream glycoprotein IIb/IIIa inhibition and coronary artery stenting in the invasive management of unstable angina/non-ST-elevation myocardial infarction: a comparison of the Thrombolysis In Myocardial Infarction (TIMI) IIIB trial and the Treat angina with Aggrastat and determine Cost of Therapy with Invasive or Conservative Strategy (TACTICS)-TIMI 18 trial.
    Sabatine MS; Morrow DA; Giugliano RP; Murphy SA; Demopoulos LA; DiBattiste PM; Weintraub WS; McCabe CH; Antman EM; Cannon CP; Braunwald E
    Circulation; 2004 Feb; 109(7):874-80. PubMed ID: 14757697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of coronary artery stents on mortality and nonfatal myocardial infarction: meta-analysis of randomized trials comparing a strategy of routine stenting with that of balloon angioplasty.
    Al Suwaidi J; Holmes DR; Salam AM; Lennon R; Berger PB
    Am Heart J; 2004 May; 147(5):815-22. PubMed ID: 15131536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful treatment with primary angioplasty of acute myocardial infarction during cerebellar hemorrhage.
    Paolillo V; Gastaldo D; Ferrero B; Sega P; Oliveri G
    J Invasive Cardiol; 2002 Sep; 14(9):562-4. PubMed ID: 12205360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is transfer for primary angioplasty better than on-site fibrinolytic therapy for acute myocardial infarction?
    Choi S
    CMAJ; 2003 Sep; 169(7):695. PubMed ID: 14517131
    [No Abstract]   [Full Text] [Related]  

  • 15. Primary coronary intervention in acute myocardial infarction.
    Kim CX; Davidson CJ
    Ital Heart J; 2004 Jun; 5 Suppl 6():76S-82S. PubMed ID: 15185919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antithrombotic treatment of NSTEMI/UAP. The interaction with PCI.
    Otterstad JE; Brosstad F
    Scand Cardiovasc J; 2004 Mar; 38(1):9-15. PubMed ID: 15204241
    [No Abstract]   [Full Text] [Related]  

  • 17. Low-molecular-weight heparins and glycoprotein IIb/IIIa inhibitors with percutaneous coronary intervention in acute coronary syndromes.
    Shimpi RA
    J Invasive Cardiol; 2003 Aug; 15(8):460-5. PubMed ID: 12890880
    [No Abstract]   [Full Text] [Related]  

  • 18. Reperfusion therapy for acute myocardial infarction with fibrinolytic therapy or combination reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition: the GUSTO V randomised trial.
    Pereira H;
    Rev Port Cardiol; 2001 Jun; 20(6):687-8. PubMed ID: 11525077
    [No Abstract]   [Full Text] [Related]  

  • 19. Cardiovascular news. C-PORT PCI.
    SoRelle R
    Circulation; 2000 Dec; 102(25):E9050-1. PubMed ID: 11138602
    [No Abstract]   [Full Text] [Related]  

  • 20. Rescue percutaneous coronary intervention: a review.
    Arora UK; Dhir M
    J Invasive Cardiol; 2005 Nov; 17(11):620-5. PubMed ID: 16264215
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.